CARP-1 Functional Mimetics: A Novel Class of Small Molecule Inhibitors of Medulloblastoma Cell Growth

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Ashour, Abdelkader E ^e   Jamal, Shazia ^a,c   Cheryan, Vino T ^a,c   Muthu, Magesh ^a,c   Zoheir, Khairy M A ^e,g   Alafeefy, Ahmed M ^f   Abd Allah, Adel R ^e   Levi, Edi ^a   Tarca, Adi L ^d   Polin, Lisa A ^c   Rishi, Arun K ^a,b,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Wayne State University   (United States)

^e KING SAUD UNIVERSITY   (Saudi Arabia)

^f PRINCE SATTAM BIN ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^g NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARP 1 FUNCTIONAL MIMETIC 1; CARP 1 FUNCTIONAL MIMETIC 4; CARP 1 FUNCTIONAL MIMETIC 5; GUANINE NUCLEOTIDE BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NEUROTROPHIN 3; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN ABIN1; PROTEIN ABIN2; PROTEIN P21; RAC1 PROTEIN; STROMELYSIN 2; TUMOR PROTEIN; UNCLASSIFIED DRUG; 1-(2-CHLOROBENZYL)-5'-PHENYL-3'H-SPIRO(INDOLINE-3,2'-(1,3,4)THIADIAZOL)-2-ONE; APOPTOSIS REGULATORY PROTEIN; CARRIER PROTEIN; CCAR1 PROTEIN, HUMAN; CELL CYCLE PROTEIN; SPIRO COMPOUND; THIADIAZOLE DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL MOTILITY; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MEDULLOBLASTOMA; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; CELL MOTION; CELL PROLIFERATION; DRUG EFFECTS; IMMUNOHISTOCHEMISTRY; METABOLISM; TUMOR CELL LINE; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; BLOTTING, WESTERN; CARRIER PROTEINS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; HUMANS; IMMUNOHISTOCHEMISTRY; MEDULLOBLASTOMA; NEUROTROPHIN 3; SPIRO COMPOUNDS; THIADIAZOLES;

EID: 84879487117     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0066733     Document Type: Article

References (50)

1. Gilbertson RJ, (2004) Medulloblastoma: signaling a change in treatment. Lancet Oncol 5: 209-218.
2. Mulhern RK, Merchant TE, Gajjar A, Reddick WE, Kun LE, (2004) Late neurocognitive sequelae of brain tumors in childhood. Lancet Oncol 5: 399-408.
3. Raaf J, Kernohan JW, (1944) Relation of abnormal collections of cells in posterior medullary velum of the cerebellum to origin of medulloblastoma. Arch Neurol Psychiatry 52: 163-172.
4. Rakic P, Sidman RL, (1970) Histogenesis of cortical layers in human cerebellum, particularly the Lamina Dissecans. J Comp Neurol 139: 473-500.
5. Kozmik Z, Sure U, Ruedi D, Busslinger M, Aguzzi A, (1995) Deregulated expression of PAX5 in medulloblastoma. Proc Natl Acad Sci USA 92: 5709-5713.
6. Segal RA, Goumnerrova LC, Kwon YK, Stiles CD, Pomeroy SL, (1994) Expression of neurotroipn receptor TrkC is linked to a favorable outcome in medulloblastoma. Proc Natl Acad Sci USA 91: 12867-12871.
7. Taylor MD, Northcott PA, Korshunov A, Remke M, Cho YJ, et al. (2012) Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathol 123: 465-472.
8. Roninson G, Parker M, Kranenburg TA, Lu C, Chen X, et al. (2012) Novel mutations target distinct subgroups of medulloblastoma. Nature 488: 43-48.
9. Benard J, Douc-Rasy S, Ahomadegbe JC, (2003) TP53 family members and human cancers. Hum. Mutat 21: 182-191.
10. Castellino RC, Bortoli MD, Lu X, Moon SH, Nguyen TA, et al. (2008) Medulloblastomas express the p53-inactivating oncogene WIP1/PPMID. J. Neurooncol. 86: 245-256.
11. Kunkele A, Preter KD, Heukamp L, Thor T, Pajtler KW, et al. (2012) Pharmacological activation of the p53 pathway by nutlin-3 exerts anti-tumoral effects in medulloblastomas. Neuro-Oncology 14: 859-869.
12. Weeraratne SD, Amani V, Neiss A, Teider N, Scott DK, et al. (2011) miR-34a confirs chemosensitivity through modulation of MAGE-A and p53 in medulloblastomas. Neuro-Oncology 13: 165-175.
13. Studebaker AW, Kreofsky CR, Pierson CR, Russell SJ, Galanis E, et al. (2010) Treatment of medulloblastoma with a modified measles virus. Neuro-Oncol 12: 1034-1042.
14. Rishi AK, Zhang L, Boyanapalli M, Wali A, Mohammad RM, et al. (2003) Identification and characterization of a Cell-Cycle and Apoptosis Regulatory Protein (CARP)-1 as a novel mediator of apoptosis signaling by Retinoid CD437. J Biol Chem 278: 33422-33435.
15. Rishi AK, Zhang L, Yu Y, Jiang Y, Nautiyal J, et al. (2006) Cell cycle and apoptosis regulatory protein (CARP)-1 is involved in apoptosis signaling by epidermal growth factor receptor. J Biol Chem 281(19): 13188-98.
16. Puliyappadamba VT, Wu W, Bevis D, Zhang L, Polin L, et al. (2011) Antagonists of anaphase promoting complex (APC)-2-cell cycle and apoptosis regulatory protein (CARP)-1 interaction are novel regulators of cell growth and apoptosis. J Biol Chem 286 (44): 38000-38017.
17. Kim JH, Yang CK, Heo K, Roeder RG, An W, et al. (2008) CCAR1, a key regulator of mediator complex recruitment to nuclear receptor transcription complexes. Mol Cell 31: 510-519.
18. Ranger A, McDonald W, Moore E, DelMaestro R, (2010) The invasiveness of the five medulloblastoma cell lines in collagen gels. J Neurooncol 96: 181-189.
19. Smyth GK, Limma L (2005) Liner models for microarray data. In: Bioinformatics and Computational Biology Solutions Using R and Bioconductor, edited by Gentleman R, Carey V, Duoit S, Irizarry R, Huber W. New York: Springer, p. 397-420.
20. Tarca AL, Carey VJ, Chen XW, Romero R, Drãghici S, (2007) Machine learning and its applications to biology. PLoS Comput Biol 3: e116.
21. Kim JYH, Sutton ME, Lu DJ, Cho TA, Goumnerova LC, et al. (1999) Activation of neurotrophin-3 receptor TrkC induces apoptosis in medulloblastomas. Can Res 59: 711-719.
22. Liang CC, Park AY, Guan JL, (2007) In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2(2): 329-33.
23. Shaw LM, (2005) Tumor cell invasion assays. Methods Mol Biol 294: 97-105.
24. Zhang L, Levi E, Majumder P, Yu Y, Aboukameel A, et al. (2007) Transactivator of transcription tagged cell cycle and apoptosis regulatory protein-1 peptides suppress growth of human breast cancer cells in vitro and in vivo. Mol Cancer Ther 6(5): 1661-1672.
25. Doroshow JH (2001) Anthracyclines and anthracenediones. Cancer and Chemotherapy: Principles and practice (3rd edition), Eds, Bruce A. Chabner and Dan L. Longo. Pages 500-537.
26. Price RD, Milne SA, Sharkey J, Matsouka N, (2007) Advances in small molecules promoting neurotrophic function. Pharmacology & Therapeutics 115: 292-306.
27. Webster NJG, Pirrung MC, (2008) Small molecule activators of the Trk receptors for neuroprotection. BioMed Central Neuroscience 9: S1.
28. Nikoletopoulou V, Lickert H, Frade JM, Rencurel C, Giallonardo P, et al. (2010) Neurotrophin receptors TrkA and TrkC cause neuronal death whereas TrkB does not. Nature 467: 59-63.
29. Casaccia-Bonnefil P, Kong H, Chao MV, (1998) Neurotrophins: the biological paradox of survival factors eliciting apoptosis. Cell Death & Differen. 5: 357-364.
30. Muragaki Y, Chou TT, Kaplan DR, Trojanowski JQ, Lee VMY, (1997) Nerve growth factor induces apoptosis in human medulloblastoma cell lines that express TrkA receptors. J Neuroscience 17: 530-542.
31. Verstrepen L, Carpentier I, Verhelst K, Beyaert R, (2009) ABINs: A20 binding inhibitors of NF-κB and apoptosis signaling. Biochem. Pharmacol. 28: 105-114.
32. Liu WK, Yen PF, Chien CY, Fann MJ, Su JY, et al. (2004) The inhibitor ABIN-2 disrupts the interaction of receptor-interacting protein with the kinase subunit IKKγ to block activation of the transcription factor NF-κB and potentiate apoptosis. Biochem. J. 378: 867-876.
33. Nakada M, Okada Y, Yamashita J, (2003) The role of matrix metalloproteinases in glioma invasion. Frnt. Biosci 8: e261-269.
34. Bodey B, Bodey B Jr, Siegel SE, Kaiser HE, (2000) Matrix metalloproteinase expression in childhood medulloblastomas/primitive neuroectodermal tumors. In Vivo 14: 667-673.
35. Vince GH, Herbold C, Klien R, (2001) Medulloblastoma displays distinct regional matrix metalloprotease expression. J. Neurooncol. 53: 99-106.
36. Annabi B, Rojas-Sutterlin S, Laflamme C, Lachambre MP, Rolland Y, et al. (2008) Tumor environment dictates medulloblastoma cancer stem cell expression and invasive phenotype. Mol Cancer Res. 6: 907-916.
37. Mills JC, Wang S, Erecinska M, Pittman RN, (1995) Use of cultured neurons, and neuronal cell lines to study morphological, biochemical, molecular changes occurring in cell death. Methods Cell Biol. 46: 217-242.
38. Barbacid M, (1995) Neurotrophic factors and their receptors. Curr Opin Cell Biol. 7: 148-155.
39. Washiyama K, Muragaki Y, Rorke LB, Lee VMY, Feinstein SC, et al. (1996) Neurotrophin and neurotrophin receptor proteins in medulloblastomas and other primitive neuroectodermal tumors of pediatric central nervous system. Am J Pathol. 148: 929-940.
40. Skeldal S, Matusica D, Nykjaer A, Coulson EJ, (2011) Proteolytic processing of the p75 neurotrophin receptor: A prerequisite for signaling? Bioassays 33: 614-625.
41. Bhakar AL, Howell JL, Paul CE, Salehi AH, Becker EBE, et al. (2003) Apoptosis induced by p75NTR overexpression requires jun kinase-dependent phosphorylation of Bad. J. Neurosci. 23: 11373-11381.
42. Yano H, Torkin R, Martin LA, Chao MV, Teng KK, (2009) Proneurotrophin-3 is a neuronal apoptotic ligand: evidence for retrograde-directed cell killing. J. Neurosci. 29: 14970-14802.
43. Kenchappa RS, Tep C, Korade Z, Urra S, Bronfman FC, et al. (2010) p75 neurotrophin receptor-mediated apoptosis in sympathetic neurons involves a biphasic activation of JNK and up-regulation of tumor necrosis factor-α-converting enzyme/ADAM17. J. Biol. Chem. 285: 20358-20368.
44. Papa S, Zazzeroni F, Pham CG, Bubici C, Franzoso G, (2004) Linking JNK signaling to NF-κB: a key to survival. J Cell Sci. 117: 5197-5208.
45. Schwenger P, Alpert D, Skolnik EY, Vilcek J, (1998) Activation of p38 mitogen-activated protein kinase by sodium salicylate leads to inhibition of tumor necrosis factor-induced IκBα phosphorylation and degradation. Mol Cell Biol. 18: 78-84.
46. Tan J, Kuang W, Jin Z, Jin F, Xu L, et al. (2009) Inhibition of NFkappaB by activated c-Jun NH2 terminal kinase 1 acts as a switch for C2C12 cell death under excessive stretch. Apoptosis 14: 764-770.
47. Perkins ND, (2007) Integrating cell-signalling pathways with NF-κB and IKK function. Nature Rev. Mol Cell Biol. 8: 49-62.
48. Karl S, Pritschow Y, Volcic M, Hacker S, Baumann B, et al. (2009) Identification of a novel pro-apoptotic function of NF-κB in the DNA damage response. J. Cell. Mol. Med. 13: 4239-4256.
49. Liu J, Yang D, Minemoto Y, Leitges M, Rosner MR, et al. (2006) NF-κB Is Required for UV-Induced JNK Activation via Induction of PKCδ. Mol Cell 21: 467-480.
50. Berger R, Jennewein C, Marscall V, Karl S, Cristofanson S, et al. (2011) NF-κB Is Required for Smac Mimetic-Mediated Sensitization of Glioblastoma Cells for γ-Irradiation-Induced Apoptosis. Mol Cancer Ther. 10: 1867-75.